Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pharmaceutical strategies to extend pulmonary exposure of inhaled medicines
Yi Guo, Hriday Bera, Changzhi Shi, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 11, Iss. 8, pp. 2565-2584
Open Access | Times Cited: 100

Showing 1-25 of 100 citing articles:

Pulmonary delivery of siRNA against acute lung injury/acute respiratory distress syndrome
Makhloufi Zoulikha, Qingqing Xiao, George Frimpong Boafo, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 12, Iss. 2, pp. 600-620
Open Access | Times Cited: 178
Application of PLGA as a Biodegradable and Biocompatible Polymer for Pulmonary Delivery of Drugs
Riya Mahar, Arpita Chakraborty, Nidhi Nainwal, et al.
AAPS PharmSciTech (2023) Vol. 24, Iss. 1
Closed Access | Times Cited: 42
Pulmonary inhalation for disease treatment: Basic research and clinical translations
Bin Wang, Lin Wang, Qian Yang, et al.
Materials Today Bio (2024) Vol. 25, pp. 100966-100966
Open Access | Times Cited: 20
Microparticles and multi-unit systems for advanced drug delivery
Nikolett Kállai-Szabó, Dóra Farkas, Miléna Lengyel, et al.
European Journal of Pharmaceutical Sciences (2024) Vol. 194, pp. 106704-106704
Open Access | Times Cited: 18
Lipid Nanoparticles as Delivery Vehicles for Inhaled Therapeutics
Ellenmae W. X. Leong, Ruowen Ge
Biomedicines (2022) Vol. 10, Iss. 9, pp. 2179-2179
Open Access | Times Cited: 69
Lipid carriers for mRNA delivery
Wanting Zhang, Yuxin Jiang, Yonglong He, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 13, Iss. 10, pp. 4105-4126
Open Access | Times Cited: 65
Mechanisms and challenges of nanocarriers as non-viral vectors of therapeutic genes for enhanced pulmonary delivery
Hezhi Wang, Qin Lu, Xin Zhang, et al.
Journal of Controlled Release (2022) Vol. 352, pp. 970-993
Open Access | Times Cited: 47
Liposomes or Extracellular Vesicles: A Comprehensive Comparison of Both Lipid Bilayer Vesicles for Pulmonary Drug Delivery
Ali Al-Jipouri, Samah Hamed Almurisi, Khater AL-Japairai, et al.
Polymers (2023) Vol. 15, Iss. 2, pp. 318-318
Open Access | Times Cited: 31
Emerging delivery approaches for targeted pulmonary fibrosis treatment
Rimpy Diwan, Himanshu Bhatt, Elfa Beaven, et al.
Advanced Drug Delivery Reviews (2023) Vol. 204, pp. 115147-115147
Open Access | Times Cited: 27
Inhalable nanomedicine for lung cancer treatment
Shuiying Zhang, Rui Li, Tong Jiang, et al.
Smart Materials in Medicine (2024) Vol. 5, Iss. 2, pp. 261-280
Open Access | Times Cited: 10
Evaluating the photodynamic efficacy of nebulized curcumin-loaded liposomes prepared by thin-film hydration and dual centrifugation: In vitro and in ovo studies
Lena Bender, Abdallah M. Ayoub, Jan Schulze, et al.
Biomaterials Advances (2024) Vol. 159, pp. 213823-213823
Open Access | Times Cited: 9
Ciprofloxacin-Loaded Inhalable Formulations against Lower Respiratory Tract Infections: Challenges, Recent Advances, and Future Perspectives
Vijay Kumar Panthi, Kathryn E. Fairfull‐Smith, Nazrul Islam
Pharmaceutics (2024) Vol. 16, Iss. 5, pp. 648-648
Open Access | Times Cited: 8
Solid Lipid Nanoparticles for Pulmonary Delivery of Biopharmaceuticals: A Review of Opportunities, Challenges, and Delivery Applications
Saniya Alwani, Ellen K. Wasan, Ildikó Badea
Molecular Pharmaceutics (2024) Vol. 21, Iss. 7, pp. 3084-3102
Closed Access | Times Cited: 8
Current trends in inhaled pharmaceuticals: challenges and opportunities in respiratory infections treatment
Kiramat Ali Shah, Anam Razzaq, Amos Dormocara, et al.
Journal of Pharmaceutical Investigation (2025)
Closed Access | Times Cited: 1
Excipient-free inhalable combination shell-core microparticles with clofazimine shell for extended pulmonary retention of isoniazid in core
Kolimi Prashanth Reddy, Lakshmi Tulasi Naraharisetti, Vani Sai Prasanna, et al.
International Journal of Pharmaceutics (2025) Vol. 672, pp. 125310-125310
Closed Access | Times Cited: 1
Therapeutic Potential of Small Molecules Targeting Oxidative Stress in the Treatment of Chronic Obstructive Pulmonary Disease (COPD): A Comprehensive Review
Hamad Ghaleb Dailah
Molecules (2022) Vol. 27, Iss. 17, pp. 5542-5542
Open Access | Times Cited: 36
Challenges and Strategies to Enhance the Systemic Absorption of Inhaled Peptides and Proteins
Qin Lu, Zhixiang Cui, Yu Wu, et al.
Pharmaceutical Research (2022) Vol. 40, Iss. 5, pp. 1037-1055
Open Access | Times Cited: 28
An inhaled ACE2 decoy confers protection against SARS-CoV-2 infection in preclinical models
Emiko Urano, Yumi Itoh, Tatsuya Suzuki, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 711
Closed Access | Times Cited: 19
Mechanisms by Which Liposomes Improve Inhaled Drug Delivery for Alveolar Diseases
Laura T. Ferguson, Xiaonan Ma, Jacob W. Myerson, et al.
Advanced NanoBiomed Research (2023) Vol. 3, Iss. 3
Open Access | Times Cited: 18
A new hope? Possibilities of therapeutic IgA antibodies in the treatment of inflammatory lung diseases
Fabian Bohländer
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 17
Inhalable microparticles as drug delivery systems to the lungs in a dry powder formulations
Karolina Knap, Konrad Kwiecień, Katarzyna Reczyńska, et al.
Regenerative Biomaterials (2022) Vol. 10
Open Access | Times Cited: 25
Biocompatible biodegradable polymeric nanocarriers in dry powder inhalers (DPIs) for pulmonary inhalation delivery
David Encinas-Basurto, Basanth Babu Eedara, Heidi M. Mansour
Journal of Pharmaceutical Investigation (2024) Vol. 54, Iss. 2, pp. 145-160
Closed Access | Times Cited: 5
Natural Products-Based Inhaled Formulations for Treating Pulmonary Diseases
Jiangyan Yong, Hongli Shu, Xiao Zhang, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 1723-1748
Open Access | Times Cited: 5
Phospholipids of inhaled liposomes determine the in vivo fate and therapeutic effects of salvianolic acid B on idiopathic pulmonary fibrosis
Jianqing Peng, Qin Wang, Runbin Sun, et al.
Journal of Controlled Release (2024) Vol. 371, pp. 1-15
Closed Access | Times Cited: 5
Inhalation drug delivery in combating pulmonary infections: Advances and challenges
Popat Kumbhar, Jaskiran Kaur, Gabriele De Rubis, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 89, pp. 105022-105022
Closed Access | Times Cited: 12
Page 1 - Next Page

Scroll to top